3-AllylglutariMide
|
- $200 - $6000
- Product name: 3-AllylglutariMide
- CAS: 918868-36-7
- MF: C8H11NO2
- MW: 153.18
- EINECS:
- MDL Number:MFCD11226883
- Synonyms:4-ALLYLPIPERIDINE-2,6-DIONE;3-AllylglutariMide;4-(2-Propen-1-yl)-2,6-piperidinedione;2,6-Piperidinedione, 4-(2-propen-1-yl)-
5 prices
Selected condition：
Brand
- AccelPharmtech
- American Custom Chemicals Corporation
- TRC
Package
- 5MG
- 250mg
- 1G
- 5G
- 25G
- ManufacturerAccelPharmtech
- Product numberR1377
- Product description4-(2-propen-1-yl)-2,6-Piperidinedione 97.00%
- Packaging25G
- Price$6000
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberR1377
- Product description4-(2-propen-1-yl)-2,6-Piperidinedione 97.00%
- Packaging5G
- Price$3230
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberR1377
- Product description4-(2-propen-1-yl)-2,6-Piperidinedione 97.00%
- Packaging1G
- Price$1890
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM1047185
- Product description3-ALLYLGLUTARIMIDE 95.00%
- Packaging5MG
- Price$505.16
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA555600
- Product description3-Allylglutarimide
- Packaging250mg
- Price$200
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AccelPharmtech | R1377 | 4-(2-propen-1-yl)-2,6-Piperidinedione 97.00% | 25G | $6000 | 2021-12-16 | Buy |
| AccelPharmtech | R1377 | 4-(2-propen-1-yl)-2,6-Piperidinedione 97.00% | 5G | $3230 | 2021-12-16 | Buy |
| AccelPharmtech | R1377 | 4-(2-propen-1-yl)-2,6-Piperidinedione 97.00% | 1G | $1890 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM1047185 | 3-ALLYLGLUTARIMIDE 95.00% | 5MG | $505.16 | 2021-12-16 | Buy |
| TRC | A555600 | 3-Allylglutarimide | 250mg | $200 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|